GNA NOW Open Call webinar recording now available

Starting with an introduction to the project, they explained in detail what the consortium is looking for with the Open Call, what’s in it for interested candidates, and how to submit an Expression of Interest (EoI).

If you were unable to attend the live sessions, a recording is now available, as are the webinar slides.

More information on the Open Call can be found here.

Interested candidates are asked to submit a non-confidential EoI, which will be evaluated by the GNA NOW Review Committee. The top three submissions will be asked to provide a full proposal.

Important deadlines:

• EoI submission: Friday 18 June 2021
• Programme proposal submission: Wednesday 25 August 2021

For any questions, please send an email to gnanow@lygature.org.

----

About GNA NOW
Established in July 2019, the GNA NOW Consortium is a European collaboration of 11 partners focused on progressing Gram-Negative antibiotics from lead optimization to the completion of Phase I trials. Working under the AMR Accelerator umbrella, the project is funded by the Innovative Medicines Initiative (IMI) with in-kind contributions from industry partner, Evotec.

More information on Lygature’s role in the consortium, can be found here.

Acknowledgement
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853979. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Disclaimer
This communication reflects the views of the GNA NOW Consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.